Christine Baudelet

14.7k total citations · 1 hit paper
55 papers, 2.6k citations indexed

About

Christine Baudelet is a scholar working on Radiology, Nuclear Medicine and Imaging, Oncology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Christine Baudelet has authored 55 papers receiving a total of 2.6k indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Radiology, Nuclear Medicine and Imaging, 18 papers in Oncology and 17 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Christine Baudelet's work include Advanced MRI Techniques and Applications (16 papers), MRI in cancer diagnosis (13 papers) and Cancer Immunotherapy and Biomarkers (12 papers). Christine Baudelet is often cited by papers focused on Advanced MRI Techniques and Applications (16 papers), MRI in cancer diagnosis (13 papers) and Cancer Immunotherapy and Biomarkers (12 papers). Christine Baudelet collaborates with scholars based in Belgium, United States and Germany. Christine Baudelet's co-authors include Bernard Gallez, Bénédicte F. Jordan, Olivier Féron, Nelson Beghein, Réginald Ansiaux, Vincent Grégoire, Nathalie Crokart, Greg O. Cron, Philippe Martinive and Ian Walters and has published in prestigious journals such as Journal of Clinical Oncology, Cancer Research and Clinical Cancer Research.

In The Last Decade

Christine Baudelet

54 papers receiving 2.5k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Nivolumab Versus Docetaxel in a Predominantly Chinese Patient Population With Previously Treated Advanced NSCLC: CheckMate 078 Randomized Phase III Clinical Trial

2019 265 citations Christine Baudelet et al. Journal of Thoracic Oncology profile →

Peers

Countries citing papers authored by Christine Baudelet

Since Specialization

Citations

This map shows the geographic impact of Christine Baudelet's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Christine Baudelet with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Christine Baudelet more than expected).

Fields of papers citing papers by Christine Baudelet

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Christine Baudelet. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Christine Baudelet. The network helps show where Christine Baudelet may publish in the future.

Co-authorship network of co-authors of Christine Baudelet

This figure shows the co-authorship network connecting the top 25 collaborators of Christine Baudelet. A scholar is included among the top collaborators of Christine Baudelet based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Christine Baudelet. Christine Baudelet is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Amivantamab plus capmatinib in advanced non-small cell lung cancer (NSCLC) harboring MET alterations: Recommended phase 2 combination dose and preliminary dose-escalation results from the phase 1/2 METalmark study. 2024 ·Journal of Clinical Oncology ·Alexander I. Spira, Byoung Chul Cho, (unknown), Sang-We Kim, Bing Xia, (unknown), Jessica Dobbs, Christine Baudelet, Mahadi Baig, Mehmet Alı Nahıt Şendur	3
2	EP.12H.02 Amivantamab, An EGFR-MET Bispecific Antibody, with Cetrelimab, An Anti-PD-1 Antibody, In Advanced NSCLC: Phase 1/2 Polydamas 2024 ·Journal of Thoracic Oncology ·(unknown), Ju Le Tan, (unknown), (unknown), (unknown), Bing Xia, (unknown), Jessica Dobbs, Christine Baudelet, Mirza Rafi Baig, (unknown), Mehmet Alı Nahıt Şendur, (unknown)	1
3	749P Nivolumab (N) alone or in combination with ipilimumab (I) in patients (pts) with platinum-pretreated metastatic urothelial carcinoma (mUC): Extended follow-up from CheckMate 032 2020 ·Annals of Oncology ·Padmanee Sharma, Arlene O. Siefker‐Radtke, Filippo de Braud, Umberto Basso, Emiliano Calvo, Petri Bono, Michael A. Morse, Paolo A. Ascierto, José A. López-Martín, Peter Brossart, Kristoffer Staal Rohrberg, Begoña Mellado, (unknown), Christine Baudelet, Keziban Ünsal-Kaçmaz, (unknown), Jonathan E. Rosenberg	9
4	ID:2908 First-Line Nivolumab + Ipilimumab vs Chemotherapy in Unresectable Malignant Pleural Mesothelioma: CheckMate 743 2020 ·Journal of Thoracic Oncology ·Paul Baas, Arnaud Scherpereel, Anna K. Nowak, Nobukazu Fujimoto, Solange Peters, Anne S. Tsao, Aaron S. Mansfield, Sanjay Popat, Thierry Jahan, Scott Antonia, Youssef Oulkhouir, Y. Bautista, Robin Cornelissen, Laurent Greillier, Francesco Grossi, Dariusz M. Kowalski, Jerónimo Rafael Rodríguez‐Cid, Praveen Aanur, Christine Baudelet, Gérard Zalcman	37
5	68P Evaluation of flat dosing for nivolumab (NIVO) + ipilimumab (IPI) in first-line (1L) unresectable malignant pleural mesothelioma (MPM): CheckMate 743 (CM 743) 2020 ·Annals of Oncology ·Anne S. Tsao, Paul Baas, Anna K. Nowak, Gérard Zalcman, Nobukazu Fujimoto, Solange Peters, Christine Baudelet, Praveen Aanur, (unknown), (unknown), (unknown), Jennifer Sheng	1
6	Nivolumab (nivo) plus ipilimumab (ipi), nivo, or placebo (pbo) as maintenance therapy in patients (pts) with extensive disease small cell lung cancer (ED-SCLC) after first-line (1L) platinum-based chemotherapy (chemo): Results from the double-blind, randomized phase III CheckMate 451 study 2019 ·Annals of Oncology ·Taofeek K. Owonikoko, (unknown), Ramaswamy Govindan, Neal Ready, Martin Reck, Solange Peters, Shaker R. Dakhil, Alejandro Navarro, Jerónimo Rafael Rodríguez‐Cid, Michael Schenker, (unknown), Vanesa Gutiérrez, Ivor Percent, Daniel Morgensztern, Justin Fairchild, Christine Baudelet, K. Park	66
7	A randomized, open-label, phase 3 study of nivolumab in combination with ipilimumab vs extreme regimen (cetuximab + cisplatin/carboplatin + fluorouracil) as first-line therapy in patients with recurrent or metastatic squamous cell carcinoma of the head and neck-CheckMate 651 2016 ·Annals of Oncology ·Athanassios Argiris, Maura L. Gillison, Robert L. Ferris, Kevin J. Harrington, (unknown), Christine Baudelet, William J. Geese, (unknown), Robert I. Haddad	19
8	Phase II, Open-Label Study of Brivanib as Second-Line Therapy in Patients with Advanced Hepatocellular Carcinoma 2012 ·Clinical Cancer Research ·Richard S. Finn, Yoon‐Koo Kang, Mary F. Mulcahy, Blasé N. Polite, Ho Yeong Lim, Ian Walters, Christine Baudelet, (unknown), Joong‐Won Park	158
9	Phase II, Open-Label Study of Brivanib as First-Line Therapy in Patients with Advanced Hepatocellular Carcinoma 2011 ·Clinical Cancer Research ·Joong‐Won Park, Richard S. Finn, (unknown), Mark Karwal, (unknown), Fuad Ismail, Melanie B. Thomas, (unknown), Christine Baudelet, Ian Walters, Jean‐Luc Raoul	110
10	A 40-week double-blind aripiprazole versus lithium follow-up of a 12-week acute phase study (total 52weeks) in bipolar I disorder 2011 ·Journal of Affective Disorders ·Rif S. El‐Mallakh, Ronald N. Marcus, Christine Baudelet, Robert D. McQuade, William H. Carson, Randall Owen	20
11	Caveolin-1 Is Critical for the Maturation of Tumor Blood Vessels through the Regulation of Both Endothelial Tube Formation and Mural Cell Recruitment 2007 ·American Journal Of Pathology ·Julie DeWever, Françoise Frérart, Caroline Bouzin, Christine Baudelet, Réginald Ansiaux, Pierre Sonveaux, Bernard Gallez, Chantal Dessy, Olivier Féron	40
12	Tumor radiosensitization by anti-inflammatory drugs: Evidence for a new mechanism involving the oxygen effect. 2006 ·Digital Access to Libraries (Université catholique de Louvain (UCL), l'Université de Namur (UNamur) and the Université Saint-Louis (USL-B)) ·(unknown), Vincent Grégoire, Kim A. Radermacher, Bénédicte F. Jordan, Christine Baudelet, (unknown), Nelson Beghein, Caroline Bouzin, Olivier Féron, Bernard Gallez	18
13	Determination of the maturity and functionality of tumor vasculature by MRI: Correlation between BOLD‐MRI and DCE‐MRI using P792 in experimental fibrosarcoma tumors 2006 ·Magnetic Resonance in Medicine ·Christine Baudelet, Greg O. Cron, Bernard Gallez	30
14	Complex relationship between changes in oxygenation status and changes in R: The case of insulin and NS‐398, two inhibitors of oxygen consumption 2006 ·Magnetic Resonance in Medicine ·Bénédicte F. Jordan, Nathalie Crokart, Christine Baudelet, Greg O. Cron, Réginald Ansiaux, Bernard Gallez	16
15	Early reoxygenation in tumors after irradiation: Determining factors and consequences for radiotherapy regimens using daily multiple fractions 2005 ·International Journal of Radiation OncologyBiologyPhysics ·Nathalie Crokart, Bénédicte F. Jordan, Christine Baudelet, Réginald Ansiaux, Pierre Sonveaux, Vincent Grégoire, Nelson Beghein, Julie DeWever, Caroline Bouzin, Olivier Féron, Bernard Gallez	82
16	Physiological noise in murine solid tumours using T2-weighted gradient-echo imaging: a marker of tumour acute hypoxia? 2004 ·Physics in Medicine and Biology* ·Christine Baudelet, Réginald Ansiaux, Bénédicte F. Jordan, Xavier Havaux, Benoı̂t Macq, Bernard Gallez	89
17	Assessment of tumor oxygenation by electron paramagnetic resonance: principles and applications 2004 ·NMR in Biomedicine ·Bernard Gallez, Christine Baudelet, Bénédicte F. Jordan	190
18	How does blood oxygen level‐dependent (BOLD) contrast correlate with oxygen partial pressure (pO₂) inside tumors? 2002 ·Magnetic Resonance in Medicine ·Christine Baudelet, Bernard Gallez	184
19	Changes in tumor oxygenation/perfusion induced by the no donor, isosorbide dinitrate, in comparison with carbogen: monitoring by EPR and MRI 2000 ·International Journal of Radiation OncologyBiologyPhysics ·Bénédicte F. Jordan, (unknown), R. Demeure, Christine Baudelet, Nelson Beghein, Bernard Gallez	94
20	Pharmacological modifications of the partial pressure of oxygen in murine tumors: Evaluation using in vivo EPR oximetry 1999 ·Magnetic Resonance in Medicine ·Bernard Gallez, Bénédicte F. Jordan, Christine Baudelet, (unknown)	90

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact